Carnitine palmitoyltransferase (CPT)-1β and the cluster of differentiation (CD)-36 protein levels were lower in the empagliflozin-treated DM group and liraglutide-treated DM group compared with the DM group (Figure 2e,f). The gene discussed is CPT1B; the disease is diabetes mellitus.